Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Non-Invasive Hemodynamic Monitoring of Cocaine-Induced Changes in Cardiac Output and Systemic Vascular Resistance in Subjects with Chronic Cocaine Use Disorder.

Van Tassell BW, Westman P, Trankle C, Johns S, Kadariya D, Buckley L, Carbone S, Abbate A, Moeller FG.

J Cardiovasc Pharmacol. 2019 Sep 2. doi: 10.1097/FJC.0000000000000740. [Epub ahead of print]

PMID:
31517776
2.

Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity and HFpEF: The UFA-Preserved Pilot Study.

Carbone S, Billingsley HE, Canada JM, Kadariya D, Medina de Chazal H, Rotelli B, Potere N, Paudel B, Markley R, Dixon DL, Trankle CR, Van Tassell BW, Celi FS, Abbate A.

JACC Basic Transl Sci. 2019 Aug 26;4(4):563-565. doi: 10.1016/j.jacbts.2019.04.001. eCollection 2019 Aug. No abstract available.

3.

Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.

Van Tassell B, Wohlford GF, Linderman JD, Smith S, Yavuz S, Pucino F, Celi FS.

Thyroid. 2019 Sep 12. doi: 10.1089/thy.2019.0101. [Epub ahead of print]

PMID:
31364488
4.

Alirocumab in Acute Myocardial Infarction: Results From the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT).

Trankle CR, Wohlford G, Buckley LF, Kadariya D, Ravindra K, Markley R, Park TS, Potere N, Van Tassell BW, Abbate A.

J Cardiovasc Pharmacol. 2019 Sep;74(3):266-269. doi: 10.1097/FJC.0000000000000706.

PMID:
31356537
5.

Metabolic modulation predicts heart failure tests performance.

Contaifer D Jr, Buckley LF, Wohlford G, Kumar NG, Morriss JM, Ranasinghe AD, Carbone S, Canada JM, Trankle C, Abbate A, Van Tassell BW, Wijesinghe DS.

PLoS One. 2019 Jun 20;14(6):e0218153. doi: 10.1371/journal.pone.0218153. eCollection 2019.

6.

The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse.

Toldo S, Mauro AG, Cutter Z, Van Tassell BW, Mezzaroma E, Del Buono MG, Prestamburgo A, Potere N, Abbate A.

J Cardiovasc Pharmacol. 2019 Apr;73(4):215-222. doi: 10.1097/FJC.0000000000000658.

PMID:
30747785
7.

Potential role for interleukin-1 in the cardio-renal syndrome.

Buckley LF, Canada JM, Carbone S, Trankle CR, Kadariya D, Billingsley H, Wohlford GF, Kirkman DL, Abbate A, Van Tassell BW.

Eur J Heart Fail. 2019 Mar;21(3):385-386. doi: 10.1002/ejhf.1403. Epub 2019 Jan 22. No abstract available.

PMID:
30666820
8.

C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction.

van Wezenbeek J, Canada JM, Ravindra K, Carbone S, Trankle CR, Kadariya D, Buckley LF, Del Buono M, Billingsley H, Viscusi M, Wohlford GF, Arena R, Van Tassell B, Abbate A.

Front Cardiovasc Med. 2018 Dec 21;5:178. doi: 10.3389/fcvm.2018.00178. eCollection 2018.

9.

Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance.

Canada JM, Abbate A, Collen R, Billingsley H, Buckley LF, Carbone S, Trankle CR, Idowu MO, Kadariya D, Van Tassell B, Sanyal AJ, Siddiqui MS.

Am J Cardiol. 2019 Feb 1;123(3):466-473. doi: 10.1016/j.amjcard.2018.10.027. Epub 2018 Nov 6.

PMID:
30502049
10.

An Orally Available NLRP3 Inflammasome Inhibitor Prevents Western Diet-Induced Cardiac Dysfunction in Mice.

Carbone S, Mauro AG, Prestamburgo A, Halquist MS, Narayan P, Potere N, Mezzaroma E, Van Tassell BW, Abbate A, Toldo S.

J Cardiovasc Pharmacol. 2018 Dec;72(6):303-307. doi: 10.1097/FJC.0000000000000628.

11.

IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot Study.

Trankle CR, Canada JM, Kadariya D, Markley R, De Chazal HM, Pinson J, Fox A, Van Tassell BW, Abbate A, Grinnan D.

Am J Respir Crit Care Med. 2019 Feb 1;199(3):381-384. doi: 10.1164/rccm.201809-1631LE. No abstract available.

PMID:
30418047
12.

IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.

Van Tassell BW, Trankle CR, Canada JM, Carbone S, Buckley L, Kadariya D, Del Buono MG, Billingsley H, Wohlford G, Viscusi M, Oddi-Erdle C, Abouzaki NA, Dixon D, Biondi-Zoccai G, Arena R, Abbate A.

Circ Heart Fail. 2018 Aug;11(8):e005036. doi: 10.1161/CIRCHEARTFAILURE.118.005036.

13.

Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein.

Trankle CR, Canada JM, Cei L, Abouzaki N, Oddi-Erdle C, Kadariya D, Christopher S, Viscusi M, Del Buono M, Kontos MC, Arena R, Van Tassell B, Abbate A.

Am J Cardiol. 2018 Oct 15;122(8):1366-1370. doi: 10.1016/j.amjcard.2018.07.002. Epub 2018 Jul 20.

14.

Low-Density Lipoprotein Receptor-Related Protein-1 Is a Therapeutic Target in Acute Myocardial Infarction.

Toldo S, Austin D, Mauro AG, Mezzaroma E, Van Tassell BW, Marchetti C, Carbone S, Mogelsvang S, Gelber C, Abbate A.

JACC Basic Transl Sci. 2017 Oct 30;2(5):561-574. doi: 10.1016/j.jacbts.2017.05.007. eCollection 2017 Oct. Erratum in: JACC Basic Transl Sci. 2018 Mar 01;3(1):162.

15.

Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction.

Carbone S, Canada JM, Buckley LF, Trankle CR, Billingsley HE, Dixon DL, Mauro AG, Dessie S, Kadariya D, Mezzaroma E, Buzzetti R, Arena R, Van Tassell BW, Toldo S, Abbate A.

JACC Basic Transl Sci. 2017 Oct 30;2(5):513-525. doi: 10.1016/j.jacbts.2017.06.009. eCollection 2017 Oct.

16.

Interleukin-1 Blockade in Acute Myocardial Infarction and Heart Failure: Getting Closer and Closer.

Toldo S, Van Tassell BW, Abbate A.

JACC Basic Transl Sci. 2017 Aug 28;2(4):431-433. doi: 10.1016/j.jacbts.2017.07.006. eCollection 2017 Aug. No abstract available.

17.

Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study.

Van Tassell BW, Lipinski MJ, Appleton D, Roberts CS, Kontos MC, Abouzaki N, Melchior R, Mueller G, Garnett J, Canada J, Carbone S, Buckley LF, Wohlford G, Kadariya D, Trankle CR, Oddi Erdle C, Sculthorpe R, Puckett L, DeWilde C, Shah K, Angiolillo DJ, Vetrovec G, Biondi-Zoccai G, Arena R, Abbate A.

Clin Cardiol. 2018 Aug;41(8):1004-1008. doi: 10.1002/clc.22988. Epub 2018 Aug 17.

18.

Erratum. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733-1738.

Buckley LF, Dixon DL, Wohlford GF 4th, Wijesinghe DS, Baker WL, Van Tassell BW.

Diabetes Care. 2018 Sep;41(9):2048. doi: 10.2337/dc18-er09. Epub 2018 Jun 18. No abstract available.

19.

The 2017 American College of Cardiology/American Heart Association hypertension guideline and opportunities for community pharmacists.

Dixon DL, Salgado TM, Caldas LM, Van Tassell BW, Sisson EM.

J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4):382-386. doi: 10.1016/j.japh.2018.04.027. Epub 2018 May 24.

PMID:
29804824
20.

Response to Comment on Buckley et al. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733-1738.

Buckley LF, Dixon DL, Wohlford GF 4th, Wijesinghe DS, Baker WL, Van Tassell BW.

Diabetes Care. 2018 Jun;41(6):e86-e87. doi: 10.2337/dci17-0066. No abstract available.

PMID:
29784701
21.

Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials.

Buckley LF, Carbone S, Trankle CR, Canada JM, Erdle CO, Regan JA, Viscusi MM, Kadariya D, Billingsley H, Arena R, Abbate A, Van Tassell BW.

J Cardiovasc Pharmacol. 2018 Jul;72(1):68-70. doi: 10.1097/FJC.0000000000000591.

22.

Inhibiting the Inflammatory Injury After Myocardial Ischemia Reperfusion With Plasma-Derived Alpha-1 Antitrypsin: A Post Hoc Analysis of the VCU-α1RT Study.

Abouzaki NA, Christopher S, Trankle C, Van Tassell BW, Carbone S, Mauro AG, Buckley L, Toldo S, Abbate A.

J Cardiovasc Pharmacol. 2018 Jun;71(6):375-379. doi: 10.1097/FJC.0000000000000583.

23.

Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics.

Carbone S, Canada JM, Billingsley HE, Kadariya D, Dixon DL, Trankle CR, Buckley LF, Markley R, Vo C, Medina de Chazal H, Christopher S, Buzzetti R, Van Tassell BW, Abbate A.

Diabetes Obes Metab. 2018 Aug;20(8):2014-2018. doi: 10.1111/dom.13309. Epub 2018 Apr 23.

24.

Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants.

Buckley LF, Dixon DL, Wohlford GF 4th, Wijesinghe DS, Baker WL, Van Tassell BW.

Diabetes Obes Metab. 2018 Jun;20(6):1499-1502. doi: 10.1111/dom.13248. Epub 2018 Mar 2.

PMID:
29424469
25.

Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction.

Buckley LF, Canada JM, Del Buono MG, Carbone S, Trankle CR, Billingsley H, Kadariya D, Arena R, Van Tassell BW, Abbate A.

ESC Heart Fail. 2018 Apr;5(2):372-378. doi: 10.1002/ehf2.12235. Epub 2018 Jan 18.

26.

Pharmacist-physician collaborative care model and time to goal blood pressure in the uninsured population.

Dixon DL, Sisson EM, Parod ED, Van Tassell BW, Nadpara PA, Carl D, W Dow A.

J Clin Hypertens (Greenwich). 2018 Jan;20(1):88-95. doi: 10.1111/jch.13150. Epub 2017 Dec 13.

27.

Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).

Van Tassell BW, Canada J, Carbone S, Trankle C, Buckley L, Oddi Erdle C, Abouzaki NA, Dixon D, Kadariya D, Christopher S, Schatz A, Regan J, Viscusi M, Del Buono M, Melchior R, Mankad P, Lu J, Sculthorpe R, Biondi-Zoccai G, Lesnefsky E, Arena R, Abbate A.

Circ Heart Fail. 2017 Nov;10(11). pii: e004373. doi: 10.1161/CIRCHEARTFAILURE.117.004373.

28.

Lack of soluble circulating cardiodepressant factors in takotsubo cardiomyopathy.

Sonnino C, Van Tassell BW, Toldo S, Del Buono MG, Moeller FG, Abbate A.

Auton Neurosci. 2017 Dec;208:170-172. doi: 10.1016/j.autneu.2017.10.010. Epub 2017 Nov 2.

PMID:
29117918
29.

Levosimendan in Advanced Heart Failure: Where Do We Stand?

Abbate A, Van Tassell BW.

J Cardiovasc Pharmacol. 2018 Mar;71(3):127-128. doi: 10.1097/FJC.0000000000000539. No abstract available.

30.

Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP.

Buckley LF, Dixon DL, Wohlford GF 4th, Wijesinghe DS, Baker WL, Van Tassell BW.

Diabetes Care. 2017 Dec;40(12):1733-1738. doi: 10.2337/dc17-1366. Epub 2017 Sep 25. Erratum in: Diabetes Care. 2018 Sep;41(9):2048.

PMID:
28947569
31.

Severely Impaired Cardiorespiratory Fitness in Patients With Recently Decompensated Systolic Heart Failure.

Canada JM, Trankle CR, Buckley LF, Carbone S, Abouzaki NA, Kadariya D, Shah K, Cooke R, Kontos MC, Patel J, Mankad P, Schatz A, Bhatnagar A, Arena R, Van Tassell BW, Abbate A.

Am J Cardiol. 2017 Nov 15;120(10):1854-1857. doi: 10.1016/j.amjcard.2017.07.099. Epub 2017 Aug 7.

32.

Impaired myocardial relaxation with exercise determines peak aerobic exercise capacity in heart failure with preserved ejection fraction.

Trankle C, Canada JM, Buckley L, Carbone S, Dixon D, Arena R, Van Tassell B, Abbate A.

ESC Heart Fail. 2017 Aug;4(3):351-355. doi: 10.1002/ehf2.12147. Epub 2017 May 6.

33.

Interleukin-1 blockade for the treatment of pericarditis.

Buckley LF, Viscusi MM, Van Tassell BW, Abbate A.

Eur Heart J Cardiovasc Pharmacother. 2018 Jan 1;4(1):46-53. doi: 10.1093/ehjcvp/pvx018. Review.

34.

Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2).

Van Tassell BW, Buckley LF, Carbone S, Trankle CR, Canada JM, Dixon DL, Abouzaki N, Oddi-Erdle C, Biondi-Zoccai G, Arena R, Abbate A.

Clin Cardiol. 2017 Sep;40(9):626-632. doi: 10.1002/clc.22719. Epub 2017 May 5.

35.

Interleukin-18 mediates cardiac dysfunction induced by western diet independent of obesity and hyperglycemia in the mouse.

Carbone S, Lee PJ, Mauro AG, Mezzaroma E, Buzzetti R, Van Tassell B, Abbate A, Toldo S.

Nutr Diabetes. 2017 Apr 10;7(4):e258. doi: 10.1038/nutd.2017.1.

36.

Unsupervised analysis of combined lipid and coagulation data reveals coagulopathy subtypes among dialysis patients.

Contaifer D Jr, Carl DE, Warncke UO, Martin EJ, Mohammed BM, Van Tassell B, Brophy DF, Chalfant CE, Wijesinghe DS.

J Lipid Res. 2017 Mar;58(3):586-599. doi: 10.1194/jlr.P068833. Epub 2016 Dec 19.

37.

Obesity Contributes to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.

Carbone S, Canada JM, Buckley LF, Trankle CR, Dixon DL, Buzzetti R, Arena R, Van Tassell BW, Abbate A.

J Am Coll Cardiol. 2016 Dec 6;68(22):2487-2488. doi: 10.1016/j.jacc.2016.08.072. No abstract available.

38.

A review of PCSK9 inhibition and its effects beyond LDL receptors.

Dixon DL, Trankle C, Buckley L, Parod E, Carbone S, Van Tassell BW, Abbate A.

J Clin Lipidol. 2016 Sep-Oct;10(5):1073-80. doi: 10.1016/j.jacl.2016.07.004. Epub 2016 Jul 20. Review.

PMID:
27678423
39.

Recombinant Human Alpha-1 Antitrypsin-Fc Fusion Protein Reduces Mouse Myocardial Inflammatory Injury After Ischemia-Reperfusion Independent of Elastase Inhibition.

Toldo S, Mauro AG, Marchetti C, Rose SW, Mezzaroma E, Van Tassell BW, Kim S, Dinarello CA, Abbate A.

J Cardiovasc Pharmacol. 2016 Jul;68(1):27-32. doi: 10.1097/FJC.0000000000000383.

PMID:
26945157
40.

Effectiveness of a Pharmacist-Physician Team-Based Collaboration to Improve Long-Term Blood Pressure Control at an Inner-City Safety-Net Clinic.

Sisson EM, Dixon DL, Kildow DC, Van Tassell BW, Carl DE, Varghese D, Electricwala B, Carroll NV.

Pharmacotherapy. 2016 Mar;36(3):342-7. doi: 10.1002/phar.1710. Epub 2016 Feb 24.

PMID:
26917116
41.

Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study.

Van Tassell BW, Abouzaki NA, Oddi Erdle C, Carbone S, Trankle CR, Melchior RD, Turlington JS, Thurber CJ, Christopher S, Dixon DL, Fronk DT, Thomas CS, Rose SW, Buckley LF, Dinarello CA, Biondi-Zoccai G, Abbate A.

J Cardiovasc Pharmacol. 2016 Jun;67(6):544-51. doi: 10.1097/FJC.0000000000000378.

42.

Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse.

Toldo S, Marchetti C, Mauro AG, Chojnacki J, Mezzaroma E, Carbone S, Zhang S, Van Tassell B, Salloum FN, Abbate A.

Int J Cardiol. 2016 Apr 15;209:215-20. doi: 10.1016/j.ijcard.2016.02.043. Epub 2016 Feb 4.

PMID:
26896627
43.

Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure.

Canada JM, Fronk DT, Cei LF, Carbone S, Erdle CO, Abouzaki NA, Melchior RD, Thomas CS, Christopher S, Turlington JS, Trankle CR, Thurber CJ, Evans RK, Dixon DL, Van Tassell BW, Arena R, Abbate A.

Am J Cardiol. 2016 Jan 1;117(1):116-20. doi: 10.1016/j.amjcard.2015.10.020. Epub 2015 Oct 19.

PMID:
26546248
44.

A mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II.

Regan JA, Mauro AG, Carbone S, Marchetti C, Gill R, Mezzaroma E, Valle Raleigh J, Salloum FN, Van Tassell BW, Abbate A, Toldo S.

Am J Physiol Heart Circ Physiol. 2015 Sep;309(5):H771-8. doi: 10.1152/ajpheart.00282.2015. Epub 2015 Jul 17.

45.

A high-sugar and high-fat diet impairs cardiac systolic and diastolic function in mice.

Carbone S, Mauro AG, Mezzaroma E, Kraskauskas D, Marchetti C, Buzzetti R, Van Tassell BW, Abbate A, Toldo S.

Int J Cardiol. 2015 Nov 1;198:66-9. doi: 10.1016/j.ijcard.2015.06.136. Epub 2015 Jul 2.

PMID:
26151718
46.

Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse.

Marchetti C, Toldo S, Chojnacki J, Mezzaroma E, Liu K, Salloum FN, Nordio A, Carbone S, Mauro AG, Das A, Zalavadia AA, Halquist MS, Federici M, Van Tassell BW, Zhang S, Abbate A.

J Cardiovasc Pharmacol. 2015 Jul;66(1):1-8. doi: 10.1097/FJC.0000000000000247.

47.

Role of Interleukin-1 in Radiation-Induced Cardiomyopathy.

Mezzaroma E, Mikkelsen RB, Toldo S, Mauro AG, Sharma K, Marchetti C, Alam A, Van Tassell BW, Gewirtz DA, Abbate A.

Mol Med. 2015 Mar 26;21:210-8. doi: 10.2119/molmed.2014.00243.

48.

Inflammatory markers in ST-elevation acute myocardial infarction.

Seropian IM, Sonnino C, Van Tassell BW, Biasucci LM, Abbate A.

Eur Heart J Acute Cardiovasc Care. 2016 Aug;5(4):382-95. doi: 10.1177/2048872615568965. Epub 2015 Feb 13. Review.

PMID:
25681486
49.

Predicting therapeutic response in patients with heart failure: the story of C-reactive protein.

Huynh K, Van Tassell B, Chow SL.

Expert Rev Cardiovasc Ther. 2015 Feb;13(2):153-61. doi: 10.1586/14779072.2015.1000307. Epub 2015 Jan 12. Review.

PMID:
25578159
50.

Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart.

Toldo S, Mezzaroma E, McGeough MD, Peña CA, Marchetti C, Sonnino C, Van Tassell BW, Salloum FN, Voelkel NF, Hoffman HM, Abbate A.

Cardiovasc Res. 2015 Feb 1;105(2):203-12. doi: 10.1093/cvr/cvu259. Epub 2014 Dec 18.

Supplemental Content

Loading ...
Support Center